Drug interactions in English: source-based medicine pair records — Page 5
How to use this directory
Each record describes a documented medicine pair and links to its source information. Coverage is selective. Missing records do not establish safe use, and these pages do not replace individual review by a qualified healthcare professional.
These records are for information and research. Do not start, stop or change medicines based on a web page. Product formulations, licensed uses and advice can differ by country.
Apalutamide and Oxycodone: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Palbociclib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Paxlovid (Nirmatrelvir/Ritonavir) (Paxlovid 150 mg/100 mg Film Kaplı Tablet): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Posaconazole: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Ribociclib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Rimegepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Riociguat: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Sotalol: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Tofacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Upadacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Venetoclax: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Voclosporin: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Warfarin (Coumadin 5 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apalutamide and Ziprasidone: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apixaban (Eliquis 5 mg) and Ibrutinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apixaban (Eliquis 5 mg) and Indomethacin: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apixaban (Eliquis 5 mg) and Ketorolac: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apixaban (Eliquis 5 mg) and Nabumetone: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apixaban (Eliquis 5 mg) and Posaconazole: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Apixaban (Eliquis 5 mg) and Treprostinil: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arcoxia 60 mg and Erlotinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arcoxia 60 mg and Tofacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arcoxia 60 mg and Upadacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arcoxia 90 mg and Erlotinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arcoxia 90 mg and Tofacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arcoxia 90 mg and Upadacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arcoxia 120 mg and Erlotinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arcoxia 120 mg and Tofacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arcoxia 120 mg and Upadacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 10 mg) and Buprenorphine: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 10 mg) and Fentanyl: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 10 mg) and Methadone: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 10 mg) and Morphine: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 10 mg) and Oxycodone: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 15 mg) and Buprenorphine: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 15 mg) and Fentanyl: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 15 mg) and Methadone: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 15 mg) and Morphine: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Aripiprazole (Abilify 15 mg) and Oxycodone: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arveles 25 mg and Erlotinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arveles 25 mg and Tenofovir disoproxil fumarate: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arveles 25 mg and Tofacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arveles 25 mg and Upadacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arveles 50 mg/2 ml Ampul and Erlotinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arveles 50 mg/2 ml Ampul and Tenofovir disoproxil fumarate: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arveles 50 mg/2 ml Ampul and Tofacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Arveles 50 mg/2 ml Ampul and Upadacitinib: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Asenapine and Bedaquiline: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Asenapine and Buprenorphine: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.